Coca Leaf on Schedule I: A Historical Anomaly
The World Health Organization (WHO), through its Expert Committee on Drug Dependence (ECDD), concluded its 48th meeting in October 2025 with a critical review of the international classification of the coca leaf. Contrary to the expectations of Indigenous communities, civil society organizations, and advocates of evidence-based policies, the WHO recommended keeping coca leaf on Schedule […] The post Coca Leaf on Schedule I: A Historical Anomaly appeared first on ICEERS.
External link. We are not responsible for the content.
Read more ↗More From ICEERS
Honoring Peace Award for Natalia Rebollo in Mexico
On February 19, the Mexican Chamber of Deputies hosted the “Honoring Peace” ceremony, an event dedicated to recognizi...
Uso de ayahuasca ou Cannabis mantém neurocognição normal
The post Uso de ayahuasca ou Cannabis mantém neurocognição normal appeared first on ICEERS.
Personality in Ayahuasca and Cannabis Users
Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users Authors:José Carlos Bou...
Latest News
A federal report encourages states to prepare for FDA approval of psychedelics; Could THC help with the psychedelic blinding problem?
Plus: Ketamine seized at the UK border hits record high; an Arizona ibogaine trial; Study reveals cell signaling that...
7 Questions I'm Obsessed With About Psychedelics Right Now
Welcome to The Psychedelic Blog. An independent media platform covering drugs, altered states & the culture surroundi...
Is “Gas Station Molly” the Next Big Grey Market Drug?
It feels like MDMA, skips the comedown, and it's already on head shop shelves. But is it legal? [...] Read More... Th...
Scent, Ritual, and Altered States
Kamila Aubre explores scent and the psychedelic experience
Inside the First Ayahuasca Forum Hosted by Indigenous Peoples
100 Indigenous leaders will gather at the World Ayahuasca Forum to set the terms for ayahuasca's future. [...] Read M...
Can Psilocybin Protect Skin Cells From Premature Aging?
PLUS Carlos Castaneda, foraging for psilocybin mushrooms, and Resilient Pharmaceuticals. [...] Read More... The post ...